When it comes to prescription medication, most people are unable to tell the difference between one type of drug and another, and they shouldn’t have to. That’s the job of pharmacists, not the average Ohio resident. In another state, though, a CVS pharmacy allegedly made a medication error that has led to a pharmaceutical litigation case after a young girl suffered serious prescription drug injuries.
In Jan. 2015, the child was being treated by physicians for her seizure disorder and other medical conditions for which she takes a variety of medications. She and her mother had one of her prescriptions filled for what they thought was glycopyrrolate, her proper medication, at a CVS pharmacy. After the girl had consumed a number of the tablets according to the instructions, however, the girl’s mother realized that, due to the pharmacy’s negligence, the girl had actually been taking the wrongly-filled prescription for a medication called glimepiride the entire time.
The medication error resulted in a vast array of injuries to the young girl, including but not limited to hypoglycemia and increased seizures. The ill effects she suffered led to three separate hospitalizations throughout the month of January and into February and resulted in a need for heightened surveillance of the child. Because the girl is a minor, her mother filed the lawsuit on her behalf.
The plaintiffs – the injured girl and her mother – request a trial by jury. For the counts of alleged negligence, punitive damages, infliction of emotional distress, breach of liability and more by the defendants, the lawsuit seeks damages in excess of $50,000 with further relief as the court sees fit. Anyone who has similarly suffered drug injuries due to the gross negligence of a doctor or pharmacist has the legal right to explore options for justice and compensation with an Ohio attorney experienced in pharmaceutical litigation cases.
Source: pennrecord.com, “Parent of child hospitalized from alleged improper prescription sues CVS Pharmacy“, Nicholas Malfitano, July 20, 2017
